#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
preLekára.sk / Journals / Journal of Czech Physicians / 2022 - 7-8

Indications for Metabolic and Bariatric Surgery – ASMBS/IFSO 2022

Česká verzia

Authors: Dan Eisenberg 1;  Scott A. Shikora 2;  Edo Aarts 3;  Ali Aminian 4;  Luigi Angrisani 5;  Ricardo V. Cohen 6;  Maurizio De Luca 7;  Silvia L. Faria 8;  Kasey P. S. Goodpaster 4;  Ashraf Haddad 9;  Jacques M. Himpens 10;  Lilian Kow 11;  Marina Kurian 12;  Kamal Mahawar 13;  Ken Loi 14;  Abdelrahman Nimeri 15;  Mary O Kane 16;  Pavlos K. Papasavas 17;  Jaime Ponce 18;  Janey S. A. Pratt 1,19;  Ann M. Rogers 20;  Kimberley E. Steele 21;  Michel Suter 22;  Shanu N. Kothari 23
Authors place of work: Department of Surgery, Stanford School of Medicine and VA Palo Alto HCS, USA 1;  Department of Surgery, Center for Metabolic & Bariatric Surgery, Brigham and Women’s Hospital, and Harvard Medical School, Boston, USA 2;  WeightWorks Clinics and Allurion Clinics, Amersfoort, Nizozemsko 3;  Bariatric & Metabolic Institute, Cleveland Clinic, USA 4;  Department of Public Health, Federico II University of Naples, Neapol, Itálie 5;  The Center for the Treatment of Obesity and Diabetes, Hospital Alemăo Oswaldo Cruz, Sao Paolo, Brazílie 6;  Department of Surgery, Rovigo Hospital, Itálie 7;  Gastrocirurgia de Brasilia, University of Brasilia, Brazílie 8;  Gastrointestinal Bariatric & Metabolic Center, Jordan Hospital, Ammán, Jordánsko 9;  Department of Surgery, Delta CHIREC Hospital, Brusel, Belgie 10;  Adelaide Bariatric Centre, Flinders University of South Australia, Adelaide, Austrálie 11;  Department of Surgery, NYU Grossman School of Medicine, New York, USA 12;  Department of General Surgery, Sunderland Royal Hospital, Velká Británie 13;  Saint George Hospital and The Sutherland Hospital, Kogarah, Nový Jižní Wales, Austrálie 14;  Department of Surgery, Carolinas Medical Center, University of North Carolina, Charlotte, USA 15;  Department of Nutrition and Dietetics, Leeds Teaching Hospitals NHS Trust, Velká Británie 16;  Division of Metabolic and Bariatric Surgery, Hartford Hospital, USA 17;  Bariatric Surgery Program, CHI Memorial Hospital, Chattanooga, USA 18;  Division of Pediatric Surgery, Lucille Packard Children’s Hospital, Palo Alto, USA 19;  Department of Surgery, Penn State Health Milton S. Hershey Medical Center, Hershey, USA 20;  Special volunteer for the National Institutes of Health, NIDDK Metabolic and Obesity Research Unit, USA 21
Published in the journal: Čas. Lék. čes. 2022; 161: 276-284
Category: Guidelines

Zdroje
  1. Consensus Development Conference Panel. Gastrointestinal Surgery for Severe Obesity. Ann Intern Med 1991; 115: 956–961. 
  2. Ogden CL, Carroll MD, Kit BK et al. Prevalence of childhood and adult obesity in the United States 2011-12. JAMA 2014; 311: 806-814.
  3. World Health Organization. World Health Report 2002. Reducing risks, promoting health life. WHO, Ženeva, 2002.
  4. Gossman H, Butsch WS, Jastreboff AM. Treating the chronic disease of obesity. Med Clin N Am 2021; 105: 983-1016.
  5. Kawai T, Autieri MV, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol 2021; 320: C37–C91.
  6. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867.
  7. Grosfeld A, Andre J, Hauguel-De Mouzon S et al. Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. J Biol Chem 2002; 277: 42953-42957.
  8. Chang SS, Eisenberg D, Zhao L et al. Chemerin activation in human obesity. Obesity (Silver Spring) 2016; 24: 1522-1529.
  9. Gloy VL, Briel M, Bhatt DL et al. Bariatric surgery versus non-surgical treatment of obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ 2013; 347: f5934.
  10. Adams TD, Davidson LE, Litwin SE et al. Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med 2017; 377: 1143-1155.
  11. Sjostrom L, Lindroos AK, Peltonen M et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-2693.
  12. Sjostrom L, Peltonen M, Jacobson P et al. Bariatric surgery and long-term cardiovascular events. JAMA 2012; 307: 56-65.
  13. Puzziferri N, Roshek TB III, Mayo HG et al. Long-term follow-up after bariatric surgery: a systematic review. JAMA 2014; 312: 935-942.
  14. Maciewjewski ML, Arterburn DE, Van Scoyoc L et al. Bariatric surgery and long-term durability of weight loss. JAMA Surg 2016; 151: 1046-1055.
  15. Schauer PR, Mingrone G, Ikramuddin S et al. Clinical outcomes of metabolic surgery: efficacy of glycemic control, weight loss, and remission of diabetes. Diabetes Care 2016; 39: 902-911.
  16. Arterburn DE, Olsen MK, Smith VA et al. Association between bariatric surgery and longterm survival. JAMA 2015; 313: 62-70.
  17. Sjostrom L, Narbro K, Sjostrom CD et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741-752.
  18. Aminian A, Al-Kurd A, Wilson R et al. Association of bariatric surgery with major adverse liver and cardiovascular outcomes in patients with biopsy-proven nonalcoholic steatohepatitis. JAMA 2021; 26: 2031-2042.
  19. Aminian A, Zajicheck A, Arterburn DE et al. Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity. JAMA 2019; 322: 1271-1282.
  20. Goldberg I, Yang J, Nie L et al. Safety of bariatric surgery in patients older than 65 years. Surg Obes Relat Dis 2019; 15: 1380-1387.
  21. Phillips BT, Shikora SA. The history of metabolic and bariatric surgery: development of standards for patient safety and efficacy. Metabolism 2018; 79: 97-107.
  22. Longitudinal Assessment of Bariatric Surgery (LABS) Consortium; Flum DR, Belle SH, King WC et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009; 361: 445–454.
  23. Buchwald H, Estok R, Fahrbach K et al. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery 2007; 142: 621–632.
  24. Arterburn DE, Telem DA, Kushner RF et al. Benefits and risks of bariatric surgery in adults: a review. JAMA 2020; 324: 879-887.
  25. American Society for Metabolic and Bariatric Surgery. Estimate of bariatric numbers, 2011-2019. ASMBS, 2021 Dostupné na: https://asmbs.org/resources/estimate-of-bariatricsurgery-numbers
  26. International Federation for the Surgery of Obesity and Metabolic Disorders. 5th IFSO Global Registry Report. IFSO, Neapol, 2019. Dostupné na: www.ifso.com/pdf/5th-ifso-global-registry-report-september-2019.pdf
  27. Rubino F, Nathan DM, Eckel RH et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Surg Obes Relat Dis 2016; 12: 1144-1162.
  28. Aminian A, Chang J, Brethauer SA et al. ASMBS updated position statement on bariatric surgery in class I obesity (BMI 30-35 kg/m2). Surg Obes Relat Dis 2018; 14: 1071-1087.
  29. Noun R, Slim R, Nasr M et al. Results of laparoscopic sleeve gastrectomy in 541 consecutive patients with low baseline body mass index (30-35 kg/m2). Obes Surg 2016; 26: 2824-2828.
  30. Varban OA, Bonham AJ, Finks JF et al. Is it worth it? Determining the health benefits of sleeve gastrectomy in patients with a body mass index < 35 kg/m2. Surg Obes Relat Dis 2020; 16: 248-253.
  31. Ikramuddin S, Komer J, Lee WJ et al. Durability of addition of Roux-en-Y gastric bypass to lifestyle intervention and medical management in achieving primary treatment goals for uncontrolled type 2 diabetes in mild to moderate obesity: a randomized control trial. Diabetes Care 2016; 39: 1510-1518.
  32. Schauer PR, Bhatt DL, Kirwan JP et al. Bariatric surgery versus intensive medical therapy for diabetes – 5-year outcomes. N Engl J Med 2017; 376: 641-651.
  33. Courcoulas AP, Belle SH, Neiberg RH et al. Three-year out-comes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial. JAMA Surg 2015; 150: 931-940.
  34. O’Brien PE, Brennan L, Laurie C et al. Intensive medical weight loss or laparoscopic adjustable gastric banding in the treatment of mild to moderate obesity: long-term follow-up of a prospective randomised trial. Obes Surg 2013; 23: 1345-1353.
  35. Parikh M, Chung M, Sheth S et al. Randomized pilot trial of bariatric surgery versus intensive medical weight management on diabetes remission in type 2 diabetes patients who do NOT meet NIH criteria for surgery and the role of soluble RAGE as a novel biomarker of success. Ann Surg 2014; 260: 617-622.
  36. Wentworth JM, Playfair J, Laurie C et al. Multidisciplinary diabetes care with and without bariatric surgery in overweight people: a randomised controlled trial. Lancet Diabetes Endocrinol 2014; 2: 545-552.
  37. Busetto L, Dixon J, De Luca M et al. Bariatric surgery in class I obesity: a position statement from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Obes Surg 2014; 24: 487-519.
  38. Rubino F, Cohen RV, Mingrone G et al. Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery. Lancet Diabetes Endocrinol 2020; 8: 640-648.
  39. World Health Organization. Obesity and overweight. Dostupné na: www.who.int/westernpacific/health-topics/obesity
  40. Misra A. Ethnic-specific criteria for classification of body mass index: a perspective for Asian Indians and American Diabetes Association position statement. Diabetes Technol Ther 2015; 17: 667-671.
  41. Hsu WC, Araneta MRG, Kanaya AM et al. BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening. Diabetes Care 2015; 38: 150-158.
  42. Gill RS, Karmali S, Sharma AM. The potential role of the Edmonton obesity staging system in determining indications for bariatric surgery. Obes Surg 2011; 21: 1947-1949.
  43. Padwal RS, Pajewski NM, Allison DB et al. Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ 2011; 183: E1059-E1066.
  44. Frattini F, Lavazza M, Rausei S et al. BMI: the weakness of a milestone in obesity management and treatment. Obes Surg 2015; 25: 1940-1941.
  45. Al-Kurd A, Grinbaum R, Mordechay-Heyn T et al. Outcomes of sleeve gastrectomy in septuagenarians. Obes Surg 2018; 28: 3895-3901.
  46. Smith ME, Bacal D, Bonham AJ et al. Perioperative and 1-year outcomes of bariatric surgery in septuagenarians: implications for patient selection. Surg Obes Relat Dis 2019; 15: 1805-1811.
  47. Edwards MA, Mazzei M, Agarwal S et al. Exploring perioperative outcomes in metabolic and bariatric surgery amongst the elderly: an analysis of the. 2015-2017 MBSAQIP database. Surg Obes Relat Dis 2021; 17: 1096-1106.
  48. Watt J, Tricco AC, Talbot-Hamon C et al. Identifying older adults at risk of harm following elective surgery: a systematic review and meta-analysis. BMC Med 2018; 16: 2.
  49. Gondal AB, Hsu CH, Zeeshan M, et al. A frailty index and the impact of frailty on postoperative outcomes in older patients after bariatric surgery. Surg Obes Relat Dis 2019; 15: 158-158.
  50. Reilly JJ, Kelly J. Long-term impact of overweight and obesity in childhood and adolescence on morbidity and premature mortality in adulthood: systematic review. Int J Obes (Lond) 2011; 35: 891-898.
  51. Olbers T, Beamish AJ, Gronowitz E et al. Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study. Lancet Diabetes Endocrinol 2017; 5: 174-183.
  52. Inge TH, Jenkins TM, Xanthakos SA et al. Long-term outcomes of bariatric surgery in adolescents with severe obesity (FABS-5+): a prospective follow-up analysis. Lancet Diabetes Endocrinol 2017; 5: 165-173.
  53. Michalsky MP, Inge TH, Jenkins TM et al. Teen-LABS consortium. Cardiovascular risk factors after adolescent bariatric surgery. Pediatrics 2018; 141: e20172485.
  54. Inge TH, Laffel LM, Jenkins TM et al. Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) and treatment options of type 2 diabetes in adolescents and youth (TODAY) consortia. Comparison of surgical and medical therapy for type 2 diabetes in severely obese adolescents. JAMA Pediatr 2018; 172: 452-460.
  55. Inge TH, Courcoulas AP, Helmrath MA. Five-year outcomes of gastric bypass in adolescents as compared with adults. Reply. N Engl J Med 2019; 380: 2136-2145.
  56. Alqahtani AR, Elahmedi M, Abdurabu HY et al. Ten-year outcomes of children and adolescents who underwent sleeve gastrectomy: weight loss, comorbidity resolution, adverse events, and growth velocity. J Am Coll Surg 2021; 233: 657-664.
  57. Pratt JSA, Browne A, Browne NT et al. ASMBS pediatric metabolic and bariatric surgery guidelines. 2018. Surg Obes Relat Dis 2018; 14: 882-901.
  58. Armstrong SC, Bolling CF, Michalsky MP et al. Pediatric metabolic and bariatric surgery: evidence, barriers, and best practices. Pediatrics 2019; 144: e20193223.
  59. Jones RE, Wood LSY, Matheson BE et al. Pilot evaluation of a multidisciplinary strategy for laparoscopic sleeve gastrectomy in adolescents and young adults with obesity and intellectual disabilities. Obes Surg 2021; 31: 3883-3887.
  60. Khatod M, Cafri G, Namba RS et al. Risk factors for total hip arthroplasty aseptic revision. J Arthroplasty 2014; 29: 1412-1417.
  61. Namba RS, Inacio MCS, Paxton EW. Risk factors associated with surgical site infection in 30,491 primary total hip replacements. J Bone Joint Surg Br 2012; 94: 1330-1338.
  62. American Association of Hip and Knee Surgeons evidence-based committee. Obesity and total joint arthroplasty: a literature-based review. J Arthroplasty 2013; 28: 714-21.
  63. Arsoy D, Woodcock JA, Lewallen DG et al. Outcomes and complications following total hip arthroplasty in the super-obese patient, BMI > 50. J Arthroplasty 2014; 29: 1899-1905.
  64. Issa K, Harwin SF, Malkani AL et al. Bariatric orthopaedics: total hip arthroplasty in super-obese patients (those with a BMI of  > 50 kg/m2). Bone Joint Surg Am 2016; 98: 180-185.
  65. Rajagopal R, Martin R, Howard JL et al. Outcomes and complications of total hip replacement in super-obese patients. Bone Joint J 2013; 95-B: 758-763.
  66. McLawhorn AS, Levack AE, Lee YY et al. Bariatric surgery improves outcomes after lower extremity arthroplasty in the morbidly obese: a propensity score-matched analysis of a New York statewide database. J Arthroplasty 2018; 33: 2062-2069.
  67. Davis AM, Wood AM, Keenan ACM et al. Does body mass index affect clinical outcome post-operatively and at five years after primary unilateral total hip replacement performed for osteoarthritis? A multivariate analysis of prospective data. J Bone Joint Surg Br 2011; 93: 1178-1182.
  68. Inacio MC, Paxton EW, Fisher D et al. Bariatric surgery prior to total joint arthroplasty may not provide dramatic improvements in post-arthroplasty surgical outcomes. J Arthroplasty 2014; 29: 1359-1364.
  69. Severson EP, Singh JA, Browne JA et al. Total knee arthroplasty in morbidly obese patients treated with bariatric surgery: a comparative study. J Arthroplasty 2012; 27: 1696-1700.
  70. Kubat E, Giori NJ, Hwa K et al. Osteoarthritis in veterans undergoing bariatric surgery is associated with decreased excess weight loss: 5-year outcomes. Surg Obes Relat Dis 2016; 12: 1426-1430.
  71. Werner BC, Kurkis GM, Gwathmey FW et al. Bariatric surgery prior to total knee arthroplasty is associated with fewer postoperative complications. J Arthroplasty 2015; 30: 81-85.
  72. Li S, Luo X, Sun H et al. Does prior bariatric surgery improve outcomes following total joint arthroplasty in the morbidly obese? A meta-analysis. J Arthroplasty 2019; 34: 577-585.
  73. Dowsey MM, Brown WA, Cochrane A et al. Effect of bariatric surgery on risk of complications after total knee arthroplasty: A randomized clinical trial. JAMA Netw Open 2022; 5: e226722.
  74. Geletzke AK, Rinaldi JM, Phillips BE et al. Prevalence of systemic inflammation and micronutrient imbalance in patients with complex abdominal hernias. J Gastrointest Surg 2014; 18: 646-655.
  75. Veilleux E, Lufti R. Obesity and ventral hernia repair: is there success in staging? J Laparoendosc Adv Surg Tech 2020; 30: 896-899.
  76. Novitsky YW, Orenstein SB. Effect of patient and hospital characteristics on outcomes of elective ventral hernia repair in the United States. Hernia 2013; 17: 639-645.
  77. Menzo ML, Hinojosa M, Carbonell A et al. American Society for Metabolic and Bariatric Surgery and American Hernia Society consensus guideline on bariatric surgery and hernia surgery. Surg Obes Relat Dis 2018; 14: 1221-1232.
  78. Yemini R, Nesher E, Carmeli I et al. Bariatric surgery is efficacious and improves access to transplantation for mobidly obese renal transplant candidates. Obes Surg 2019; 29: 2373-2380.
  79. Al-Bahri S, Fakhry TK, Gonzalvo JP et al. Bariatric surgery as a bridge to renal transplantation in patiens with end-stage renal disease. Obes Surg 2017; 27: 2951-55.
  80. Lee Y, Tian C, Lovrics O et al. Bariatric surgery before, during, and after liver transplantation: a systematic review and meta-analysis. Surg Obes Relat Dis 2020; 16: 1336-1347.
  81. Yemini R, Nesher E, Braun M et al. Long-term outcomes of Roux-en-Y gastric bypass or sleeve gastrectomy in patients with cirrhosis; before, during or after liver transplantation: A single center’s experience. Clin Transplant 2021; 35: e14374.
  82. Lee Y, Anvari S, Sam Soon M et al. Bariatric surgery as a bridge to heart transplantation in morbidly obese patients. A systematic review and meta-analysis. Cardiol Rev 2022; 30: 1-7.
  83. Lim CP, Fisher OM, Falkenback D et al. Bariatric surgery provides a "bridge to transplant" for morbidly obese patients with advanced heart failure and may obviate the need for transplantation. Obes Surg 2016; 26: 486-493.
  84. McElderry B, Alvarez P, Hanna M et al. Outcomes of bariatric surgery in patients with left ventricular assist device. J Heart Lung Transplant 2022; 41: 914-918.
  85. Orandi BJ, Purvis JW, Cannon RM et al. Bariatric surgery to achieve transplant in endstage organ disease patients: a systematic review and meta-analysis. Am J Surg 2020; 220: 566-579.
  86. Laurenius A, Taha O, Maleckas A et al. Laparoscopic biliopancreatic diversion/duodenal switch or laparoscopic Roux-en-Y gastric bypass for super-obesity-weight loss versus side effects. Surg Obes Relat Dis 2010; 6: 408-416.
  87. Prachand VN, DaVee RT, Alverdy JC. Duodenal switch provides superior weight loss in the super-obese (BMI > 50 kg/m2) compared with the gastric bypass. Ann Surg 2006; 244: 611-619.
  88. Whitlock G, Lewington S, Sherliker P et al. Body mass index and cause-specific mortality in 900,000 adults: collaborative analyses of prospective studies. Lancet 2009; 373: 1083-1096.
  89. Flum DR, Belle SH, King WC et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009; 361: 445-454.
  90. DeMaria EJ. Bariatric surgery for morbid obesity. N Engl J Med 2007; 356: 2176-2183.
  91. Wilkinson KH, Helm M, Lak K et al. The risk of post-operative complications in supersuperobesity compared to superobesity in accredited bariatric surgery centers. Obes Surg 2019; 29: 2964-2971.
  92. Stephens DJ, Saunders JK, Belsley S et al. Short-term outcomes for super-super obese (BMI >60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass. Surg Obes Relat Dis 2008; 4: 408-415.
  93. Roland JC, Needleman BJ, Muscarella P et al. Laparoscopic Roux-en-Y gastric bypass in patients with body mass index >70 kg/m2. Surg Obes Relat Dis 2011; 7: 587-591.
  94. Patton H, Heimbach J, McCullough A. AGA clinical practice update on bariatric surgery in cirrhosis: expert review. Clin Gastroenterol Hepatol 2021; 19: 436-445.
  95. Lassailly G, Caiazzo R, Ntandja-Wandji LC et al. Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis. Gastroenterology 2020; 159: 1290-1301.
  96. Ahmed S, Pouwels S, Parmar C et al. Global bariatric research collaborative. Outcomes of bariatric surgery in patients with liver cirrhosis: a systematic review. Obes Surg 2021; 31: 2255-2267.
  97. Mumtaz K, Lipshultz H, Jalil S et al. Bariatric surgery in patients with cirrhosis: careful patient and surgery-type selection is key to improving outcomes. Obes Surg 2020; 30: 3444-3452.
  98. Hanipah ZN, Punchai S, McCullough A et al. Bariatric surgery in patients with cirrhosis and portal hypertension. Obes Surg 2018; 28: 3431-3438.
  99. Hirji SA, Sabatino ME, Minhas AMK et al. Contemporary nationwide heart transplantation and left ventricular assist device outcomes in patients with histories of bariatric surgery. J Card Fail 2022; 28: 330-333.
  100. Yang TWW, Johari Y, Burton PR et al. Bariatric surgery in patients with severe heart failure. Obes Surg 2020; 30: 2863-2869.
  101. McCloskey CA, Ramani GV, Mathier MA et al. Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy. Surg Obes Relat Dis 2007; 3: 503-507.
  102. Punchai S, Hanipah ZN, Sharm G et al. Laparoscopic sleeve gastrectomy in heart failure patients with left ventricular assist device. Obes Surg 2019; 29: 1122-1129.
  103. Mechanick JL, Apovian C, Brethauer S et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric surgery-2019 update: co-sponsored by the American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, and American Society of Anesthesiologists – executive summary. Endoc Pract 2019; 25: 1346-1359.
  104. Carter J, Chang J, Birriel J et al. ASMBS position statement on preoperative patient optimization before metabolic and bariatric surgery. Surg Obes Relat Dis 2021; 17: 1956-1976.
  105. Eisenberg D, Lohnberg JA, Kubat EP et al. Systems innovation model: an integrated interdisciplinary team approach pre- and post-bariatric surgery at a Veterans affairs (VA) medical center. Surg Obes Relat Dis 2017; 13: 600-606.
  106. Mechanick JL, Kushner RF, Sugerman HJ et al. American Association of Clinical Endocrinologists, The Obesity Society, and the American Society for Metabolic and Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Obesity (Silver Spring) 2009; 17 Suppl 1: S1-S70.
  107. Rebibo L, Marechal V, De Lameth I et al. Compliance with a multidisciplinary team meeting’s decision prior to bariatric surgery protects against major postoperative complications. Surg Obes Relat Dis 2017; 13: 1537-1543.
  108. Bullen NL, Parmar J, Gilbert J et al. How effective is the multidisciplinary team approach in bariatric surgery? Obes Surg 2019; 29: 3232-3238.
  109. Kim J, Rogers A, Ballem et al. ASMBS updated position statement on insurance mandated preoperative weight loss requirements. Surg Obes Relat Dis 2016; 12: 955-959.
  110. Andromalos L, Crowley N, Brown J et al. Nutritional care in bariatric surgery: An Academy Evidence Analysis Center systematic review. J Acad Nutr Diet 2019; 119: 678-686.
  111. Sogg S, Lauretti J, West-Smith L. Recommendations for the presurgical psychosocial evaluation of bariatric surgery patients. Surg Obes Relat Dis 2016; 12: 731-49.
  112. Brethauer SA, Kim J, El Chaar M et al. Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis 2015; 11: 489-506.
  113. Salminen P, Grönroos S, Helmiö M et al. Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity: The SLEEVEPASS randomized clinical trial. JAMA Surg. 2022; 157: 656–666.
  114. Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-1737.
  115. Arterburn DE, Wellman R, Emiliano A et al. Comparative effectiveness and safety of bariatric procedures for weight loss: a PCORnet cohort study. Ann Intern Med 2018; 169: 741-750.
  116. Sjostrom L, Peltonen M, Jacobson P et al. Association of bariatric surgery with longterm remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 2014; 311: 2297-2304.
  117. O’Brien PE, Hindle A, Brennan L et al. Long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-year outcomes after adjustable gastric banding. Obes Surg 2019; 29: 3-14.
  118. Guh DP, Zhang W, Bansback N et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009; 9: 88.
  119. Mentias A, Aminian A, Youssef D et al. Long-term cardiovascular outcomes after bariatric surgery in the medicare population. J Am Coll Cardiol 2022; 79: 1429-1437.
  120. Ke Z, Zhou X, Sun F et al. Effect of bariatric surgery versus medical therapy on longterm cardiovascular risk in low BMI Chinese patients with type 2 diabetes: a propensity score-matched analysis. Surg Obes Relat Dis 2022; 18: 475-483.
  121. Colquitt JL, Picket K, Loveman E et al. Surgery for weight loss in adults. Cochrane Database Syst Rev 2014; 2014: CD003641.
  122. Sjoholm K, Sjostrom E, Carlsson LMS et al. Weight change-adjusted effects of gastric bypass surgery on glucose metabolism: 2- and 10-year results from the Swedish Obese Subjects (SOS) study. Diabetes Care 2016; 39: 625-631.
  123. Mingrone G, Panunzi S, De Gaetano A et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5-year follow-up of an open-label, single centre, randomised controlled trial. Lancet 2015; 386: 964-973.
  124. Docherty NG, le Roux CW. Bariatric surgery for the treatment of chronic kidney disease in obesity and type 2 diabetes mellitus. Nature Rev Nephr 2020; 16: 709-720.
  125. Morales E, Porrini E, Martin-Toboada M et al. Renoprotective role of bariatric surgery in patients with established chronic kidney disease. Clin Kidney J 2020; 14: 2037-2046.
  126. Cohen RV, Pereira TV, Aboud CM et al. Effect of gastric bypass vs best medical treatment on early-stage chronic kidney disease in patients with type 2 diabetes and obesity. A randomized clinical trial. JAMA Surg 2020; 155: e200420.
  127. Young L, Hanipah ZN, Brethauer SA et al. Long-term impact of bariatric surgery in diabetic nephropathy. Surg Endosc 2019; 33: 1654-1660.
  128. Li H, Boakye D, Chen X et al. Association of body mass index with risk of early-onset colorectal cancer: systematic review and meta-analysis. Am J Gastroenterol 2021; 116: 2173-2183.
  129. Lauby-Secretan B, Scoccianti C, Loomis D et al. Body fatness and cancer-viewpoint of the IARC working group. N Engl J Med 2016; 375: 794-798.
  130. Schauer DP, Feigelson HS, Koebnick C et al. Bariatric surgery and the risk of cancer in a large multisite cohort. Ann Surg 2019; 269: 95-101.
  131. Esposito K, Chiodini P, Colao A et al. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care 2012; 35: 2402-2411.
  132. Economides A, Giannakou K, Mamais I et al. Association between aggressive clinicopathologic features of papillary thyroid carcinoma and body mass index: A systematic review and meta-analysis. Fron Endocrinol (Lausanne) 2021; 12: 692879.
  133. Shi J, Zhao L, Gao Y et al. Associating the risk of three urinary cancers with obesity and overweight: an overview with evidence mapping of systematic reviews. Syst Rev 2021; 10: 58.
  134. Adams TD, Hunt SC. Cancer and obesity: Effect of bariatric surgery. World J Surg 2009; 33: 2028-2033.
  135. Sjostrom L, Gummesson A, Sjostrom CD et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol 2009; 10: 653-662.
  136. Anveden A, Taube M, Peltonen M et al. Long-term incidence of female-specific cancer after bariatric surgery or usual care in the Swedish Obese Subjects Study. Gynecol Oncol 2017; 145: 224-229.
  137. Aminian A, Wilson R, Al-Kurd A et al. Association of bariatric surgery with cancer risk and mortality in adults with obesity. JAMA 2022; 327: 2423-2433.
  138. Tao W, Santoni G, von Euler-Chelpin M et al. Cancer risk after bariatric surgery in a cohort study from the five Nordic countries. Obes Surg 2020; 30: 3761-3767.
  139. Adams TD, Gress RE, Smith SC et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007; 357: 753-761.
  140. Syn NL, Cummings DE, Wang LZ et al. Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with. 174772 participants. Lancet 2021; 397: 1830-1841.
  141. Aleassa EM, Hassan M, Hayes K et al. Effect of revisional bariatric surgery on type 2 diabetes mellitus. Surg Endosc 2019; 33: 2642-2648.
  142. McKenna D, Selzer D, Burchett M et al. Revisional bariatric surgery is more effective for improving obesity related comorbidities than it is for reinducing major weight loss. Surg Obes Relat Dis 2014; 10: 654-660.
  143. Yan J, Cohen R, Aminian A. Reoperative bariatric surgery for treatment of type 2 diabetes mellitus. Surg Obes Relat Dis 2017; 13: 1412-1421.
  144. Ma P, Reddy S, HIga KD. Revisional bariatric/metabolic surgery: what dictates its indications? Curr Atheroscler Rep 2016; 18: 42.
  145. Brethauer SA, Kothari S, Kallies K et al. Systematic review on reoperative bariatric surgery: American Society for Metabolic and Bariatric Surgery revision task force. Surg Obes Relat Dis 2014; 10: 952-972.
  146. Lazzati A, Bechet S, Jouma S et al. Revision surgery after sleeve gastrectomy: a nationwide study with 10 years of follow-up. Surg Obes Relat Dis 2020; 16: 1497-1504.
  147. Tran DD, Nwokeabia ID, Purnell S et al. Revision of Roux-en-Y gastric bypass for weight regain: a systematic review of techniques and outcomes. Obes Surg 2016; 26: 1627-1634.
  148. Nevo N, Abu-Abeid S, Lahat G et al. Converting a sleeve gastrectomy to a gastric bypass for weight loss failure – is it worth it? Obes Surg 2018; 28: 364-368.

Originální publikace

Eisenberg D, Shikora SA et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. Surg Obes Relat Dis 2022 Dec; 18: 1345–1356, doi: 10.1016/j.soard.2022.08.013.

Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental Hygienist
Článek ÚVODEM
Článek The International Code of Medical Ethics of the World Medical Association
Článek In 2022, a new version of the Code of Ethics was adopted by the World Medical Association (WMA) – what new features does it bring?
Článek Ethical principles for the usage and sharing of genomic data from research
Článek Innovative Bariatric Procedures and Ethics in Bariatric Surgery: the IFSO Position Statement
Článek Practical recommendations for the management of children after kidney and liver transplantation
Článek Permanent urethral catheter – a good servant, but bad master: Guidelines for prevention, diagnosis, and treatment of catheter-associated urinary tract infections
Článek Prescription rules of hormone replacement therapy and its alternative
Článek Low levels of vitamin D in population exposed to significant environmental pollution
Článek The use of extracorporeal membrane oxygenation in the treatment of critical course of pneumonia
Článek COVID-19 infection elicits textbook immune response
Článek Trends in spa and balneology in postcovid era, outcomes, and perspectives
Článek The Fellowship of Czech Physicians in Prague and its activities in recent decades
Článek 160 years of Czech medicine through the prism of 16 jubilees of the Fellowship of Czech Physicians on the pages of the Journal of Czech Physicians
Článek Zemřel profesor Miroslav Ryska
Článok vyšiel v časopise

Journal of Czech Physicians

Číslo 7-8
2022 Číslo 7-8
Stáhnout celé číslo v PDF
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#